Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Laboratory Technician - Endocrinology

NationWide Specialist Laboratories needs a Laboratory technician to work in our busy veterinary hormone lab. We run samples from mainly dogs, cats and horses for a wide variety of hormones using RIA and ELISA techniques and biochemistry/drug monitoring on a biochemistry analyser. We also have an expanding PCR facility.
Excellent care and attention to detail is essential and a positive "can do" attitude.
Previous experience would be an advantage but not essential as full training will be given.
Full job description available on request.

Senior Project Manager

ABOUT RXCELERATE

The RxCelerate Group is a drug discovery and development service provider with clients ranging from virtual biotech companies to global pharmaceutical organisations in Europe and the USA. We design and deliver a range of drug discovery projects from concept through to early clinical development and provide Project Management resources to our clients.

Mursla Bio’s EvoLiver Surpasses Current Standards in Liver Cancer Surveillance, Data Presented at AASLD Liver Meeting 2024

·   EvoLiver™ demonstrated 86% early-stage sensitivity at 88% specificity for liver cancer surveillance among cirrhotic, high-risk patients with diverse etiologies                     
·  Validates clinical value of multi-omics content in organ-specific extracellular vesicles for liver cancer detection
·  Data presented at AASLD Liver Meeting, held 15-19 November 2024, San Diego, CA

AI Innovation is Powering the Net Zero Transition, as Patent Activity Soars in the Energy Sector According to Marks & Clerk’s 2024 AI Report

  • Green AI patents see sharp uptick as EU regulations fuel innovation in sustainable energy
  • Whilst overall AI patent filings have slowed, green AI patent publications grew 35% in 2023
  • European applicants dominate green AI, filing almost 50% more patents than US counterparts

100 Guests and Stevenage Sixth Form Students Attend International Men’s Day Talks and Wellbeing Workshop at SBC

We were delighted to welcome over 100 guests to International Men’s Day at Stevenage Bioscience Catalyst. As part of our series of diversity and inclusion events this year, which have included International Women’s Day and PRIDE, we hosted talks, a Q&A and a wellbeing workshop to promote gender inclusivity, equality and allyship at SBC.

Microbiotica Announces First Patient Dosed in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients

Cambridge, UK – 13 November 2024: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that the first patient has been dosed in its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis (UC) patients. This international trial is due to recruit up to 30 adult patients at clinical centres in the UK, Austria, Bulgaria, Poland and Spain. Initial data readouts are expected by the end of 2025.

Subscribe to